These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

317 related items for PubMed ID: 26297933

  • 1. A clinical trial of Integra Template for diabetic foot ulcer treatment.
    Driver VR, Lavery LA, Reyzelman AM, Dutra TG, Dove CR, Kotsis SV, Kim HM, Chung KC.
    Wound Repair Regen; 2015; 23(6):891-900. PubMed ID: 26297933
    [Abstract] [Full Text] [Related]

  • 2. A Prospective, Randomized, Blinded, Controlled Trial Comparing Transdermal Continuous Oxygen Delivery to Moist Wound Therapy for the Treatment of Diabetic Foot Ulcers.
    Driver VR, Reyzelman A, Kawalec J, French M.
    Ostomy Wound Manage; 2017 Apr; 63(4):12-28. PubMed ID: 28448266
    [Abstract] [Full Text] [Related]

  • 3. A Prospective, Randomized, Multicenter, Controlled Evaluation of the Use of Dehydrated Amniotic Membrane Allograft Compared to Standard of Care for the Closure of Chronic Diabetic Foot Ulcer.
    Snyder RJ, Shimozaki K, Tallis A, Kerzner M, Reyzelman A, Lintzeris D, Bell D, Rutan RL, Rosenblum B.
    Wounds; 2016 Mar; 28(3):70-7. PubMed ID: 26978860
    [Abstract] [Full Text] [Related]

  • 4. Beta-adrenergic antagonist for the healing of chronic diabetic foot ulcers: study protocol for a prospective, randomized, double-blinded, controlled and parallel-group study.
    Kaur R, Tchanque-Fossuo C, West K, Hadian Y, Gallegos A, Yoon D, Ismailyan L, Schaefer S, Dahle SE, Isseroff RR.
    Trials; 2020 Jun 08; 21(1):496. PubMed ID: 32513257
    [Abstract] [Full Text] [Related]

  • 5. High-dose folic acid and its effect on early stage diabetic foot ulcer wound healing.
    Boykin JV, Hoke GD, Driscoll CR, Dharmaraj BS.
    Wound Repair Regen; 2020 Jul 08; 28(4):517-525. PubMed ID: 32141182
    [Abstract] [Full Text] [Related]

  • 6. A multicentre prospective randomised controlled comparative parallel study of dehydrated human umbilical cord (EpiCord) allograft for the treatment of diabetic foot ulcers.
    Tettelbach W, Cazzell S, Sigal F, Caporusso JM, Agnew PS, Hanft J, Dove C.
    Int Wound J; 2019 Feb 08; 16(1):122-130. PubMed ID: 30246926
    [Abstract] [Full Text] [Related]

  • 7. A Prospective, Descriptive Study to Assess the Clinical Benefits of Using Calendula officinalis Hydroglycolic Extract for the Topical Treatment of Diabetic Foot Ulcers.
    Buzzi M, de Freitas F, Winter M.
    Ostomy Wound Manage; 2016 Mar 08; 62(3):8-24. PubMed ID: 26978856
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of tissue engineering products for the management of neuropathic diabetic foot ulcers: an interim analysis.
    Frykberg RG, Cazzell SM, Arroyo-Rivera J, Tallis A, Reyzelman AM, Saba F, Warren L, Stouch BC, Gilbert TW.
    J Wound Care; 2016 Jul 01; 25(Sup7):S18-S25. PubMed ID: 29027848
    [Abstract] [Full Text] [Related]

  • 9. A randomized clinical trial of a human acellular dermal matrix demonstrated superior healing rates for chronic diabetic foot ulcers over conventional care and an active acellular dermal matrix comparator.
    Cazzell S, Vayser D, Pham H, Walters J, Reyzelman A, Samsell B, Dorsch K, Moore M.
    Wound Repair Regen; 2017 May 01; 25(3):483-497. PubMed ID: 28544150
    [Abstract] [Full Text] [Related]

  • 10. Topical administration of a connexin43-based peptide augments healing of chronic neuropathic diabetic foot ulcers: A multicenter, randomized trial.
    Grek CL, Prasad GM, Viswanathan V, Armstrong DG, Gourdie RG, Ghatnekar GS.
    Wound Repair Regen; 2015 May 01; 23(2):203-12. PubMed ID: 25703647
    [Abstract] [Full Text] [Related]

  • 11. A post-hoc analysis of reduction in diabetic foot ulcer size at 4 weeks as a predictor of healing by 12 weeks.
    Snyder RJ, Cardinal M, Dauphinée DM, Stavosky J.
    Ostomy Wound Manage; 2010 Mar 01; 56(3):44-50. PubMed ID: 20368673
    [Abstract] [Full Text] [Related]

  • 12. Human fibroblast-derived dermal substitute: results from a treatment investigational device exemption (TIDE) study in diabetic foot ulcers.
    Warriner RA, Cardinal M, TIDE Investigators.
    Adv Skin Wound Care; 2011 Jul 01; 24(7):306-11. PubMed ID: 21685733
    [Abstract] [Full Text] [Related]

  • 13. Hyaluronic acid dressing (Healoderm) in the treatment of diabetic foot ulcer: A prospective, randomized, placebo-controlled, single-center study.
    Lee M, Han SH, Choi WJ, Chung KH, Lee JW.
    Wound Repair Regen; 2016 May 01; 24(3):581-8. PubMed ID: 26972358
    [Abstract] [Full Text] [Related]

  • 14. Topical Esmolol Hydrochloride as a Novel Treatment Modality for Diabetic Foot Ulcers: A Phase 3 Randomized Clinical Trial.
    Rastogi A, Kulkarni SA, Agarwal S, Akhtar M, Arsule S, Bhamre S, Bhosle D, Desai S, Deshmukh M, Giriraja KV, Jagannath J, Kashiva RY, Kesavan R, Khandelwal D, Kolte S, Kongara S, Darivemula AK, Madhusudan C, Pyare Saheb Qureshi MAH, Ramu M, Rathod G, Yalamanchi SR, Shakya S, Shetty P, Singh S, Deshpande SK, Viswanathan V, Unnikrishnan AG.
    JAMA Netw Open; 2023 May 01; 6(5):e2311509. PubMed ID: 37184839
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of Recombinant Human Epidermal Growth Factor (Regen-D 150) in Healing Diabetic Foot Ulcers: A Hospital-Based Randomized Controlled Trial.
    Viswanathan V, Juttada U, Babu M.
    Int J Low Extrem Wounds; 2020 Jun 01; 19(2):158-164. PubMed ID: 31878810
    [Abstract] [Full Text] [Related]

  • 16. Continuous diffusion of oxygen improves diabetic foot ulcer healing when compared with a placebo control: a randomised, double-blind, multicentre study.
    Niederauer MQ, Michalek JE, Liu Q, Papas KK, Lavery LA, Armstrong DG.
    J Wound Care; 2018 Sep 01; 27(Sup9):S30-S45. PubMed ID: 30207844
    [Abstract] [Full Text] [Related]

  • 17. Topical application of the bee hive protectant propolis is well tolerated and improves human diabetic foot ulcer healing in a prospective feasibility study.
    Henshaw FR, Bolton T, Nube V, Hood A, Veldhoen D, Pfrunder L, McKew GL, Macleod C, McLennan SV, Twigg SM.
    J Diabetes Complications; 2014 Sep 01; 28(6):850-7. PubMed ID: 25239451
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of Wound Closure Rates Using a Human Fibroblast-derived Dermal Substitute Versus a Fetal Bovine Collagen Dressing: A Retrospective Study.
    Fitzgerald RH, Sabolinski ML, Skornicki M.
    Wound Manag Prev; 2019 Sep 01; 65(9):26-34. PubMed ID: 31702990
    [Abstract] [Full Text] [Related]

  • 19. Cost-effectiveness of clostridial collagenase ointment on wound closure in patients with diabetic foot ulcers: economic analysis of results from a multicenter, randomized, open-label trial.
    Motley TA, Gilligan AM, Lange DL, Waycaster CR, Dickerson JE.
    J Foot Ankle Res; 2015 Sep 01; 8():7. PubMed ID: 25767565
    [Abstract] [Full Text] [Related]

  • 20. Wound closure in patients with DFU: a cost-effectiveness analysis of two cellular/tissue-derived products.
    Gilligan AM, Waycaster CR, Landsman AL.
    J Wound Care; 2015 Mar 01; 24(3):149-56. PubMed ID: 25764960
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.